skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Carcinoembryonic Antigen Peptide 1-6D (Code C2622)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Carcinoembryonic Antigen Peptide 1-6D

Definition: A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.

Label: Carcinoembryonic Antigen Peptide 1-6D

NCI Thesaurus Code: C2622 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0935801  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
CAP-1-6D Peptide
Carcinoembryonic Antigen Peptide 1-6D
CEA:571-579 (576D)
mCEA Peptide
Modified CEA Peptide

External Source Codes: 
NSC Code 701524 (see NCI DTP info)
PDQ Closed Trial Search ID 38236
PDQ Open Trial Search ID 38236 (check for NCI PDQ open clinical trial info)
UMLS CUI C0935801

Other Properties:
     Name Value (qualifiers indented underneath)
code C2622
Legacy_Concept_Name CEA_571-579_Peptide
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom